Research facilitated by automated quantification of biomarkers.

At Tribvn Healthcare we have developed solutions for the quantification and identification of biomarkers, including image analysis modules that are fully automated and reproducible. Features that have been developed for all of your research activities.

Our imaging solutions increase productivity and the speed at which your research is carried out, thanks to :

  • High-speed work capability on a collection of slides
  • Robust slide analysis
  • Time-saving
  • New tools: companion tests for targeted therapy

Pharma and Biotech

At TRIBVN Healthcare we provide our expertise to pharmaceutical companies. We assist them with their research and their approval and inspection requirements. Digital pathology also enables manufacturers to carry out high-speed screening of molecules and to work effectively on a collection of slides such as Drug Discovery or Toxicopathology.

Screening machines also meet the specific requirements of biotechnological research companies, as well as research aimed at therapeutic discovery, prevention and diagnosis. At Tribvn Healthcare we specialize in diagnosis and assisting with the development of companion tests.

Histopathology research

Tribvn Healthcare software solutions help researchers improve the productivity of their quantitative histopathological research. Our automated image analysis modules are designed to meet our clients’ requirements. They aide enumeration and accurate measurement thanks to screening technology, so processing a large collection of slides or a particular area of interest is easier for researchers.

Work even faster thanks to the image and data management capabilities provided by CaloPix. All your biopathology imaging and related data can be centralized in a single searchable database, making it easier to compare, sort, arrange or search your slides.

The development of companion tests

Research laboratories are facing new challenges. Discovering and approving biomarkers to identify and select groups of homogeneous patients eligible for medication specifically suited to their illness will actually enable the development of increasingly personalized treatments. The development of targeted therapies is gaining traction and consequently companions tests are also being developed.

Linked to medications, biomarkers improve the quality and efficacy of therapeutic solutions. As well as offering targeted treatments they are also used for screening and collecting predictive information intended to help improve patient healthcare.

The increasing importance of companion tests reinforces the need for precise research, including the quantification of biomarkers. Image analysis algorithms created by Tribvn Healthcare enable the rigorous and robust quantification of slides.  

Find out more about solutions from TRIBVN Healthcare